Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2017

Open Access 01-12-2017 | Research article

Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance

Authors: Fernando Teiichi Costa Oikawa, Whady Hueb, Cesar Higa Nomura, Alexandre Ciappina Hueb, Alexandre Volney Villa, Leandro Menezes Alves da Costa, Rodrigo Morel Vieira de Melo, Paulo Cury Rezende, Carlos Alexandre Wainrober Segre, Cibele Larrosa Garzillo, Eduardo Gomes Lima, Jose Antonio Franchini Ramires, Roberto Kalil Filho

Published in: Journal of Cardiothoracic Surgery | Issue 1/2017

Login to get access

Abstract

Background

The diagnosis of peri-procedural myocardial infarction is complex, especially after the emergence of high-sensitivity markers of myocardial necrosis.

Methods

In this study, patients with normal baseline cardiac biomarkers and formal indication for elective on-pump coronary bypass surgery were evaluated. Electrocardiograms, cardiac biomarkers, and cardiac magnetic resonance imaging with late gadolinium enhancement were performed before and after procedures. Myocardial infarction was defined as more than ten times the upper reference limit of the 99th percentile for troponin I and for creatine kinase isoform (CK-MB) and by the findings of new late gadolinium enhancement on cardiac magnetic resonance. We assessed the release of cardiac biomarkers in patients with no evidence of myocardial infarction on cardiac magnetic resonance.

Results

Of 75 patients referred for on-pump coronary bypass surgery, 54 (100%) did not have evidence of myocardial infarction on cardiac magnetic resonance. However, all had a peak troponin I above the 99th percentile; 52 (96%) had an elevation 10 times higher than the 99th percentile. Regarding CK-MB, 54 (100%) patients had a peak CK-MB above the 99th percentile limit, and only 13 (24%) had an elevation greater than 10 times the 99th percentile. The median value of troponin I peak was 3.15 (1.2 to 3.9) ng/mL, which represented 78.7 times the 99th percentile.

Conclusion

In this study, different from CK-MB findings, troponin was significantly increased in the absence of myocardial infarction on cardiac magnetic resonance. Thus, CK-MB was more accurate than troponin I for excluding procedure-related myocardial infarction. These data suggest a higher troponin cutoff for the diagnosis of coronary bypass surgery related myocardial infarction.

Clinical trial registration

Literature
1.
go back to reference Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.CrossRefPubMed
2.
go back to reference Swaanenburg JC, Loef BG, Volmer M, et al. Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. Clinical Chem. 2001;47(3):584–7. Swaanenburg JC, Loef BG, Volmer M, et al. Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. Clinical Chem. 2001;47(3):584–7.
3.
go back to reference Pichon H, Chocron S, Alwan K, et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation. 1997;96(1):316–20.PubMed Pichon H, Chocron S, Alwan K, et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation. 1997;96(1):316–20.PubMed
4.
go back to reference Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clinical Chem. 2009;55(1):101–8.CrossRef Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clinical Chem. 2009;55(1):101–8.CrossRef
5.
go back to reference Testa L, Van Gaal WJ, Biondi Zoccai GG, et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM. 2009;102(6):369–78.CrossRefPubMed Testa L, Van Gaal WJ, Biondi Zoccai GG, et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM. 2009;102(6):369–78.CrossRefPubMed
6.
go back to reference Hueb W, Gersh BJ, Rezende PC, et al. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V trial. BMC Cardiovasc Disord. 2012;12:65.CrossRefPubMedPubMedCentral Hueb W, Gersh BJ, Rezende PC, et al. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V trial. BMC Cardiovasc Disord. 2012;12:65.CrossRefPubMedPubMedCentral
7.
go back to reference Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357(9249):21–8.CrossRefPubMed Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357(9249):21–8.CrossRefPubMed
8.
go back to reference KC W, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97(8):765–72.CrossRef KC W, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97(8):765–72.CrossRef
9.
go back to reference Selvanayagam JB, Petersen SE, Francis JM, et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation. 2004;109(3):345–50.CrossRefPubMed Selvanayagam JB, Petersen SE, Francis JM, et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation. 2004;109(3):345–50.CrossRefPubMed
10.
go back to reference Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461–74.CrossRefPubMed Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461–74.CrossRefPubMed
11.
go back to reference Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of peri procedural myocardial necrosis after percutaneous coronary intervention: insights from delayed enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006;114:662–9. https://doi.org/10.1161/CIRCULATIONAHA.105.593210.CrossRefPubMed Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of peri procedural myocardial necrosis after percutaneous coronary intervention: insights from delayed enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006;114:662–9. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​105.​593210.CrossRefPubMed
12.
go back to reference Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7(5):775–82. doi:10.1080/10976640500295516.CrossRefPubMed Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7(5):775–82. doi:10.​1080/​1097664050029551​6.CrossRefPubMed
13.
go back to reference Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2001;40(1):139–46.CrossRef Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2001;40(1):139–46.CrossRef
14.
go back to reference Gober V, Hohl A, Gahl B, et al. Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery. PLoS One. 2013;8(9):e74241.CrossRefPubMedPubMedCentral Gober V, Hohl A, Gahl B, et al. Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery. PLoS One. 2013;8(9):e74241.CrossRefPubMedPubMedCentral
15.
go back to reference Pegg TJ, Maunsell Z, Karamitsos TD, et al. Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI. Heart. 2011;97(10):810–6.CrossRefPubMed Pegg TJ, Maunsell Z, Karamitsos TD, et al. Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI. Heart. 2011;97(10):810–6.CrossRefPubMed
16.
go back to reference van Gaal WJ, Arnold JR, Testa L, et al. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging. Eur Secur. 2011;6(6):703–10. van Gaal WJ, Arnold JR, Testa L, et al. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging. Eur Secur. 2011;6(6):703–10.
17.
go back to reference Fellahi JL, Gue X, Richomme X, et al. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology. 2003;99(2):270–4.CrossRefPubMed Fellahi JL, Gue X, Richomme X, et al. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology. 2003;99(2):270–4.CrossRefPubMed
18.
go back to reference Wang TK, Stewart RA, Ramanathan T, et al. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care. 2013;2(4):323–33.CrossRefPubMedPubMedCentral Wang TK, Stewart RA, Ramanathan T, et al. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care. 2013;2(4):323–33.CrossRefPubMedPubMedCentral
19.
go back to reference White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57(24):2406–8.CrossRefPubMed White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57(24):2406–8.CrossRefPubMed
20.
go back to reference Lewandrowski KB. Cardiac markers of myocardial necrosis: a history and discussion of milestones and emerging new trends, Clin Lab Med. 34(1) (2014) 31–41, xi. Lewandrowski KB. Cardiac markers of myocardial necrosis: a history and discussion of milestones and emerging new trends, Clin Lab Med. 34(1) (2014) 31–41, xi.
21.
go back to reference Araújo MP, Mesquita ET. Avaliação de Marcadores Prognósticos na Síndrome Coronariana Aguda sem Supradesnivelamento do Segmento ST na Sala de Emergência. SOCERJ. 2005:50–6. Araújo MP, Mesquita ET. Avaliação de Marcadores Prognósticos na Síndrome Coronariana Aguda sem Supradesnivelamento do Segmento ST na Sala de Emergência. SOCERJ. 2005:50–6.
22.
go back to reference Ramasamy I. Biochemical markers in acute coronary syndrome. Clin Chim Acta. 2011;412(15–16):1279.CrossRefPubMed Ramasamy I. Biochemical markers in acute coronary syndrome. Clin Chim Acta. 2011;412(15–16):1279.CrossRefPubMed
Metadata
Title
Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance
Authors
Fernando Teiichi Costa Oikawa
Whady Hueb
Cesar Higa Nomura
Alexandre Ciappina Hueb
Alexandre Volney Villa
Leandro Menezes Alves da Costa
Rodrigo Morel Vieira de Melo
Paulo Cury Rezende
Carlos Alexandre Wainrober Segre
Cibele Larrosa Garzillo
Eduardo Gomes Lima
Jose Antonio Franchini Ramires
Roberto Kalil Filho
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2017
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-017-0684-3

Other articles of this Issue 1/2017

Journal of Cardiothoracic Surgery 1/2017 Go to the issue